Toroso Investments, LLC Neurocrine Biosciences Inc Transaction History

Toroso Investments, LLC

  • $5.6 Billion
  • Q1 2024

A detailed history of Toroso Investments, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Toroso Investments, LLC holds 9,542 shares of NBIX stock, worth $1.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,542
Previous 6,045 57.85%
Holding current value
$1.31 Million
Previous $796,000 65.33%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$130.4 - $143.74 $456,008 - $502,658
3,497 Added 57.85%
9,542 $1.32 Million
Q4 2023

Feb 14, 2024
BUY
$106.07 - $132.76 $417,915 - $523,074
3,940 Added 187.17%
6,045 $796,000
Q3 2023

Nov 15, 2023
BUY
$94.02 - $117.1 $197,912 - $246,495
2,105 New
2,105 $236,000
Q1 2023

May 15, 2023
BUY
$94.11 - $123.02 $193,584 - $253,052
2,057 New
2,057 $208,000
Q2 2022

Aug 15, 2022
SELL
$75.79 - $100.07 $238,283 - $314,620
-3,144 Closed
0 $0
Q1 2022

May 20, 2022
BUY
$72.45 - $94.81 $29,124 - $38,113
402 Added 14.66%
3,144 $295,000
Q4 2021

Feb 16, 2022
BUY
$79.65 - $106.22 $39,028 - $52,047
490 Added 21.76%
2,742 $233,000
Q3 2021

Nov 15, 2021
BUY
$86.18 - $99.03 $194,077 - $223,015
2,252 New
2,252 $216,000
Q2 2021

Aug 13, 2021
SELL
$89.43 - $102.27 $230,639 - $263,754
-2,579 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$87.57 - $119.4 $225,843 - $307,932
2,579 New
2,579 $251,000
Q3 2020

Nov 16, 2020
SELL
$96.16 - $135.15 $215,975 - $303,546
-2,246 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$85.09 - $130.36 $191,112 - $292,788
2,246 New
2,246 $274,000

Others Institutions Holding NBIX

# of Institutions
628
Shares Held
94.4M
Call Options Held
505K
Put Options Held
343K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email